PMID- 35717493 OWN - NLM STAT- MEDLINE DCOM- 20220621 LR - 20230119 IS - 2041-4889 (Electronic) VI - 13 IP - 6 DP - 2022 Jun 18 TI - Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation. PG - 556 LID - 10.1038/s41419-022-05014-1 [doi] LID - 556 AB - High-grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy mainly due to its extensive metastasis. Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3), a newly discovered splice variant of solute carrier organic anion transporter family member 1B3 (SLCO1B3), has been reported to be overexpressed in several types of cancer. However, the biological function of Ct-OATP1B3 remains largely unknown. Here, we reveal that Ct-OATP1B3 is overexpressed in HGSOC and promotes the metastasis of HGSOC in vivo and in vitro. Mechanically, Ct-OATP1B3 directly interacts with insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), an RNA-binding protein, which results in enhancement of the mRNA stability and expression of carnitine palmitoyltransferase 1A (CPT1A) and NADH:Ubiquinone Oxidoreductase Subunit A2 (NDUFA2), leading to increased mitochondrial fatty acid beta-oxidation (FAO) and oxidative phosphorylation (OXPHOS) activities. The increased FAO and OXPHOS activities further facilitate adenosine triphosphate (ATP) production and cellular lamellipodia formation, which is the initial step in the processes of tumor cell migration and invasion. Taken together, our study provides an insight into the function and underlying mechanism of Ct-OATP1B3 in HGSOC metastasis, and highlights Ct-OATP1B3 as a novel prognostic marker as well as therapeutic target in HGSOC. CI - (c) 2022. The Author(s). FAU - Huang, Yutang AU - Huang Y AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. FAU - Du, Yan AU - Du Y AD - Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China. AD - Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, 200032, China. FAU - Zheng, Yujie AU - Zheng Y AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. FAU - Wen, Chunjie AU - Wen C AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. FAU - Zou, Hecun AU - Zou H AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. FAU - Huang, Jiafeng AU - Huang J AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. FAU - Zhou, Honghao AU - Zhou H AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. AD - Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, China. FAU - Zhao, Hongbo AU - Zhao H AUID- ORCID: 0000-0002-7523-9134 AD - Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China. zhaohongbo01@sina.com. AD - Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, 200032, China. zhaohongbo01@sina.com. AD - Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, 200011, China. zhaohongbo01@sina.com. FAU - Wu, Lanxiang AU - Wu L AUID- ORCID: 0000-0002-6687-2552 AD - Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. lxwu@cqmu.edu.cn. AD - Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, Chongqing, 400016, China. lxwu@cqmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220618 PL - England TA - Cell Death Dis JT - Cell death & disease JID - 101524092 RN - 0 (Fatty Acids) RN - 0 (IGF2BP2 protein, human) RN - 0 (Organic Anion Transporters) RN - 0 (RNA-Binding Proteins) SB - IM MH - Fatty Acids MH - Female MH - Humans MH - *Organic Anion Transporters MH - *Ovarian Neoplasms/genetics MH - Oxidative Phosphorylation MH - RNA-Binding Proteins PMC - PMC9206684 COIS- The authors declare no competing interests. EDAT- 2022/06/19 06:00 MHDA- 2022/06/22 06:00 PMCR- 2022/06/18 CRDT- 2022/06/18 23:52 PHST- 2021/09/01 00:00 [received] PHST- 2022/06/09 00:00 [accepted] PHST- 2022/06/08 00:00 [revised] PHST- 2022/06/18 23:52 [entrez] PHST- 2022/06/19 06:00 [pubmed] PHST- 2022/06/22 06:00 [medline] PHST- 2022/06/18 00:00 [pmc-release] AID - 10.1038/s41419-022-05014-1 [pii] AID - 5014 [pii] AID - 10.1038/s41419-022-05014-1 [doi] PST - epublish SO - Cell Death Dis. 2022 Jun 18;13(6):556. doi: 10.1038/s41419-022-05014-1.